Features Screener Stocks Charts
Sign In Sign Up

Divis Laboratories Ltd. Cash Flow Statement

NSE:DIVISLAB | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.57x

DIVISLAB's operating cash flow covered 57% of net income in FY 2025. Some earnings may be tied up in working capital.

Free Cash Flow

₹2.15B

DIVISLAB's free cash flow was ₹2.15B in FY 2025, down 16.7% from FY 2024.

Dividend Coverage

0.3x

DIVISLAB's free cash flow did not fully cover dividends in FY 2025. The company may be funding dividends from reserves or borrowings.

CapEx Intensity

87.0%

Capital expenditure consumed 87.0% of operating cash flow in FY 2025 for DIVISLAB, typical of capital-intensive industries.

2-year DIVISLAB cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 21.63B 29.16B
Cash flow Operating Activities 12.61B 16.53B
Investments in PPE -10.03B -14.38B
Cash flow Investing Activities -2.69B -8.04B
Dividend Paid -7.96B -7.96B
Cash flow Financing Activities -7.99B -7.99B
Cash at beginning of period 1.70B 3.63B
Cash at end of period 3.63B 4.13B
Free Cash Flow 2.58B 2.15B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025